Biologyarticle2026-11-03

Integrated manufacturing platform for cortical organoids reveals early phosphatase and prefoldin dysregulation in MAPT V337M neurons

Open access19 citations

Abstract

Human pluripotent stem cell (hPSC)-derived cortical organoids are powerful models but are often limited by low efficiency, variability, and stress-related artifacts. To address these challenges, we developed a scalable organoid platform with end-to-end quality control (QC) metrics spanning manufacturing and single-cell RNA-sequencing (scRNA-seq), developed using eight MAPT mutation isogenic line sets relevant to frontotemporal dementia (FTD-tau). Using a 96 slit-well format, we achieved ~100% organoid formation across 64 lines. Controlled-release FGF2 enhanced hPSC pluripotency and reduced mesendodermal contaminants, while optimized SB431542 dosing enhanced cortical patterning across lines with variable TGFBR1/ALK5 expression. The resulting organoids displayed transcriptomic profiles and low-stress signatures closely aligned with the developing human cortex. Applying a cortical organoid scRNA-seq index (CortiCOSI), we identified early dysregulation of phosphatase regulators ( PPP2CA, ANP32A ) and the prefoldin subunit PFDN6 in MAPT V337M excitatory neurons before tau hyperphosphorylation and oligomerization. This platform improves scalability, reproducibility, and mechanistic insight in cortical organoid studies.

// Source

View paper (DOI)Open access versionOpenAlexnpj DementiaPublished 2026-11-03

Authors: Taylor B. Bertucci, Kathryn R. Bowles, Steven Lotz, Le Qi, Susan K. Goderie, Susan M. Borden, Keith Lane, Ryan Lotz, Hailey Lotz, Rebecca Chowdhury, Shona Joy, David C. Butler, Brigitte L. Arduini, Carl Alexander Sandhof, M. Catarina Silva, Stephen J. Haggarty, Celeste M M. Karch, Leander Dony, Barbara Treutlein, Daniel H. Geschwind, Alison Goate, Sally Temple

Institutions: University of California, Los Angeles, Icahn School of Medicine at Mount Sinai, Harvard University, Washington University in St. Louis, University of Edinburgh, ETH Zurich, Massachusetts General Hospital, Ospedale Policlinico San Martino, UK Dementia Research Institute, Helmholtz Munich, Center for Systems Biology, IRCCS Azienda Ospedaliera Metropolitana, Neural Stem Cell Institute, Institute of Computational Biology